Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CRT-DRIVE: Cardiac Resynchronization Therapy Delivery Guided Non-Invasive Electrical and Venous Anatomy Assessment

NCT05327062 is registered in ClinicalTrials.gov with XSpline S.p.A. as lead sponsor.

NCT NCT05327062
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05327062 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CRT-DRIVE: Cardiac Resynchronization Therapy Delivery Guided Non-Invasive Electrical and Venous Anatomy Assessment
Lead sponsor
XSpline S.p.A.
Phase
Not applicable
Overall status
Recruiting
Start date
March 6, 2023
Completion date
September 30, 2025
Enrollment
150 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac resynchronization therapy, chronic heart failure, left bundle-branch block